l 694,458 has been researched along with selegiline in 2 studies
Studies (l 694,458) | Trials (l 694,458) | Recent Studies (post-2010) (l 694,458) | Studies (selegiline) | Trials (selegiline) | Recent Studies (post-2010) (selegiline) |
---|---|---|---|---|---|
29 | 0 | 10 | 2,575 | 319 | 394 |
Protein | Taxonomy | l 694,458 (IC50) | selegiline (IC50) |
---|---|---|---|
Cholinesterase | Homo sapiens (human) | 0.0055 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.0039 | |
Alpha-2A adrenergic receptor | Homo sapiens (human) | 1.798 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.376 | |
Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | 0.2127 | |
Amine oxidase [flavin-containing] A | Rattus norvegicus (Norway rat) | 0.9046 | |
Amine oxidase [flavin-containing] A | Homo sapiens (human) | 1.4408 | |
Adenosine receptor A1 | Rattus norvegicus (Norway rat) | 0.0067 | |
Amine oxidase [flavin-containing] B | Homo sapiens (human) | 0.1001 | |
Type-1 angiotensin II receptor | Sus scrofa (pig) | 0.048 | |
Alpha-synuclein | Homo sapiens (human) | 0.27 | |
Amine oxidase [flavin-containing] B | Bos taurus (cattle) | 1 | |
Sigma intracellular receptor 2 | Rattus norvegicus (Norway rat) | 0.017 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dansette, PM; Fontana, E; Poli, SM | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
1 review(s) available for l 694,458 and selegiline
Article | Year |
---|---|
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.
Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Isoenzymes; Structure-Activity Relationship; Terminology as Topic | 2005 |
1 other study(ies) available for l 694,458 and selegiline
Article | Year |
---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |